Written Question · S1W-09625 · Session 1
Whether the drug Trastu'umab (Herceptin) will be made available to health boards for the treatment of metastatic breast cancer.
The question
To ask the Scottish Executive whether the drug Trastu'umab (Herceptin) will be made available to health boards for the treatment of metastatic breast cancer.
The answer
The treatment of patients with breast cancer is a matter for specialists experienced in the management of cancer and the question of whether individual patients might benefit from treatment with Trastuzumab (Herceptin) is a matter for the clinical judgement of the specialist concerned.
In the Official Report
No contribution in the Official Report cites S1W-09625 by reference.